CEA Antibody (DA036)
CEA Antibody (DA036)
Recombinant monoclonal rabbit antibody
Description
CEA(Carcinoembryonic antigen) is expressed at very low levels in normal mucosal epithelium and other tissues of the adult colon,and it is highly expressed in gastrointestinal adenocarcinoma (including pancreatic) , lung adenocarcinoma and medullary thyroid carcinoma. CEA is a protein thought to promote tumor development through its role as a cell adhesion molecule. Anti-CEA positivity is seen in adenocarcinomas of many origins, especially colon and lung adenocarcinomas, but rarely seen in mesothelial cells and mesotheliomas. 1-5
References
1. Tron, V et al. "Carcinoembryonic antigen and milk-fat globule protein staining of malignant mesothelioma and adenocarcinoma of the lung." Archives of pathology & laboratory medicine vol. 111,3 (1987): 291-3.
2. Abutaily, A S et al. "Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies." Journal of clinical pathology vol. 55,9 (2002): 662-8.
3. Carella, R et al. "Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis." The American journal of surgical pathology vol. 25,1 (2001): 43-50.
4. Bhatnagar, Julu et al. "Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms." Anticancer research vol. 22,3 (2002): 1849-57.
5. Lagendijk, J H et al. "Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach." Journal of clinical pathology vol. 52,4 (1999): 283-90.
2. Abutaily, A S et al. "Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies." Journal of clinical pathology vol. 55,9 (2002): 662-8.
3. Carella, R et al. "Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis." The American journal of surgical pathology vol. 25,1 (2001): 43-50.
4. Bhatnagar, Julu et al. "Immunohistochemical detection of carcinoembryonic antigen in esophageal carcinomas: a comparison with other gastrointestinal neoplasms." Anticancer research vol. 22,3 (2002): 1849-57.
5. Lagendijk, J H et al. "Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach." Journal of clinical pathology vol. 52,4 (1999): 283-90.
Specifications
Application:
IHC (FFPE)
Host:
Rabbit
Subclass:
IgG
Immunogen:
Synthetic peptide of human CEA
Cellular location:
Cytoplasm/Cell membrane
Control:
Appendix
Order information
| RPB1A010 | Concentrate | IVD(R) |
| RPB1A010 | 10 ml Ready to use | IVD(R) |
| RPB1A010 | 6 ml Ready to use | IVD(R) |
| RPB1A010 | 3 ml Ready to use | IVD(R) |
